These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25988615)

  • 41. C16 and C17 substituted derivatives of pregnenolone and progesterone as inhibitors of 17alpha-hydroxylase-C17, 20-lyase: synthesis and biological evaluation.
    Haidar S; Hartmann RW
    Arch Pharm (Weinheim); 2002; 335(11-12):526-34. PubMed ID: 12596217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of [3α-(3) H] 17α-hydroxy pregnenolone and [3α-(3) H] pregnenolone.
    Tian Y; Hong Y; Bonacorsi SJ; Balog A; Gong S
    J Labelled Comp Radiopharm; 2014 Jan; 57(1):1-11. PubMed ID: 24448740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.
    Lézé MP; Palusczak A; Hartmann RW; Le Borgne M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4713-5. PubMed ID: 18640836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of the novel substrate-heme complex approach in the derivation of a representation of the active site of the enzyme complex 17alpha-hydroxylase and 17,20-lyase.
    Ahmed S
    Biochem Biophys Res Commun; 2004 Apr; 316(3):595-8. PubMed ID: 15033441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineering, expression, and purification of "soluble" human cytochrome P45017alpha and its functional characterization.
    Pechurskaya TA; Lukashevich OP; Gilep AA; Usanov SA
    Biochemistry (Mosc); 2008 Jul; 73(7):806-11. PubMed ID: 18707589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytochrome b(5) modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis.
    Akhtar MK; Kelly SL; Kaderbhai MA
    J Endocrinol; 2005 Nov; 187(2):267-74. PubMed ID: 16293774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and molecular docking of amide and urea derivatives as Escherichia coli PDHc-E1 inhibitors.
    He JB; Ren YL; Sun QS; You GY; Zhang L; Zou P; Feng LL; Wan J; He HW
    Bioorg Med Chem; 2014 Jun; 22(12):3180-6. PubMed ID: 24800939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
    Zolottsev VA; Tkachev YV; Latysheva AS; Kostin VA; Novikov RA; Timofeev VP; Morozevich GE; Kuzikov AV; Shumyantseva VV; Misharin AY
    Steroids; 2018 Jan; 129():24-34. PubMed ID: 29183745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors.
    Hu Q; Yin L; Jagusch C; Hille UE; Hartmann RW
    J Med Chem; 2010 Jul; 53(13):5049-53. PubMed ID: 20550118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
    Yin L; Hu Q; Emmerich J; Lo MM; Metzger E; Ali A; Hartmann RW
    J Med Chem; 2014 Jun; 57(12):5179-89. PubMed ID: 24899257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of novel derivatives of oxindole, their urease inhibition and molecular docking studies.
    Taha M; Ismail NH; Khan A; Shah SA; Anwar A; Halim SA; Fatmi MQ; Imran S; Rahim F; Khan KM
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3285-9. PubMed ID: 26077497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity.
    Szalóki G; Pantzou A; Prousis KC; Mavrofrydi O; Papazafiri P; Calogeropoulou T
    Bioorg Med Chem; 2014 Dec; 22(24):6980-8. PubMed ID: 25456391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, cytotoxicity, docking study, and tubulin polymerization inhibitory activity of novel 1-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxanilides.
    Aly OM; Beshr EA; Maklad RM; Mustafa M; Gamal-Eldeen AM
    Arch Pharm (Weinheim); 2014 Sep; 347(9):658-67. PubMed ID: 24996189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1.
    Cui YL; Zheng QC; Zhang JL; Xue Q; Wang Y; Zhang HX
    J Chem Inf Model; 2013 Dec; 53(12):3308-17. PubMed ID: 24205838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.
    Weintraub PM; Holland AK; Gates CA; Moore WR; Resvick RJ; Bey P; Peet NP
    Bioorg Med Chem; 2003 Feb; 11(3):427-31. PubMed ID: 12517438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis.
    Voets M; Antes I; Scherer C; Müller-Vieira U; Biemel K; Barassin C; Marchais-Oberwinkler S; Hartmann RW
    J Med Chem; 2005 Oct; 48(21):6632-42. PubMed ID: 16220979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular modelling of 17 alpha-hydroxylase-17,20-lyase.
    Schappach A; Höltje HD
    Pharmazie; 2001 Jun; 56(6):435-42. PubMed ID: 11446160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
    Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L
    Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.